openPR Logo
Press release

Chronic Idiopathic Constipation (CIC) Treatment Market is Expected to Generate Huge Profits byy 2025

12-21-2017 11:56 AM CET | Health & Medicine

Press release from: Transparency Market Research

Chronic Idiopathic Constipation (CIC) Treatment Market

Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation is unclear or unknown and not because of underlying illness or medication. As cause of constipation is unclear, it is called idiopathic constipation. Often chronic idiopathic constipation is indicated with multiple symptoms. The repeatedly occurring most common symptoms include abdominal discomfort, bloating, gas pain, incomplete evacuation, hard stool, and straining at the time of bowel movement.

Request Report TOC @ https://www.transparencymarketresearch.com/chronic-idiopathic-constipation-treatment-market.html

Chronic idiopathic constipation occurs without an identifiable cause. Several factors contribute to constipation including change in water balance and motility in colon. The rate at which muscles in colon contract to help pass through the stool is referred as motility. If colon absorbs more water, the stool can be hard, dry, and difficult to pass. The infrequent bowel movement could be due to dry, hard stool leading to chronic idiopathic constipation. If motility is slower down, the stool movement can be difficult to pass which results in infrequent bowel movement. This slow movement results in more water absorption and leads to hard, dry stool.

A survey found chronic idiopathic constipation common in 56% women, 44% men. It has been observed more common in adult aged or older people. Out of patients suffering from chronic idiopathic constipation only 12% are medically diagnosed and 40% are actively seeking treatment. Increasing incidence, prevalence, and growing awareness can be considered the major factors driving the global chronic idiopathic constipation treatment market. Rising prescription opioid consumption, increasing geriatric population, rising health care expenditure, launch of targeted medicines, and growing awareness are likely to drive the chronic idiopathic constipation treatment market during the forecast period.

Request For Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20537

The global chronic idiopathic constipation treatment market has been segmented based on type, type of administration, region, and distribution channel. In terms of type, the market has been segmented into pharmacological treatment and non-pharmacological treatment. Pharmacological treatment consists of stool softener, laxatives, bulk forming agents, emollients, osmotic agents, chloride channel activators, and others. Based on type of administration, the global chronic idiopathic constipation treatment market has been categorized into oral and parenteral. In terms of distribution channel, the market has been divided into independent pharmacies, drug stores, and hospital pharmacies. The data obtained from the National Center for Biotechnology Information revealed that 4 million people in the U.S. have frequent constipation, corresponding to prevalence of 2%. The laxatives and stool softeners segments are expected to account for major share of the global chronic constipation market during the forecast period in comparison to other class of drugs.

Geographically, the global chronic idiopathic constipation treatment market has been segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to hold major share of the chronic idiopathic constipation treatment market owing to significant percentage of population suffering from CIC. Europe was the second largest market for chronic idiopathic constipation treatment due to high prevalence rate. India, China, and Japan are likely to fuel the growth of the global chronic idiopathic constipation market in Asia Pacific. Abbott Gut-Health Survey reported that 14% people in India suffer from constipation. Mexico and Brazil are the high potential growth markets in Latin America because of improvement of medical infrastructure.

Pre Book full report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=22727<ype=S

Major players in the global chronic idiopathic constipation treatment market include Boehringer Ingelheim GmbH, Bayer AG, C. B. Fleet Company, Inc., Daewoong Co. Ltd., Synergy Pharmaceuticals, Inc., Actavis, Ironwood Pharmaceuticals, Cosmo Pharmaceuticals, and Sucampo Pharmaceuticals, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Idiopathic Constipation (CIC) Treatment Market is Expected to Generate Huge Profits byy 2025 here

News-ID: 871673 • Views: 159

More Releases from Transparency Market Research

Ambient Food Packaging Market to Register Substantial Expansion in Next 5 Years …
Ambient food packaging refers to packing a food product in pasteurised and sterilized packs to increase its shelf life. Ambient food packing has become a trend in the food packaging industry and ambient food products are preferred by majority of the consumers over others. Increasing demand for having more empty space in chill cabinets calls for the adoption of the food packaging methods that can offer a better shelf life
Horizontal Fan Coil Market is set to Garner Staggering Revenues by 2027 - TMR
Global Fan Coil Unit Market: Overview According to a new market report pertaining to the global fan coil unit market published by Transparency Market Research the global fan coil unit market is anticipated to reach volume of 11,378.2 thousand units by 2027. The fan coil unit market is projected to expand at a CAGR of 3.6 % from 2019 to 2027 in terms of sale. Growth of the fan coil unit
RTC IC Market – Opportunities in Key Application Sectors by 2029
Global Real-time Clock (RTC) IC Market: Introduction Transparency Market Research delivers key insights on the global real-time clock (RTC) IC market. In terms of revenue, the global real-time clock IC market is estimated to expand at a CAGR of ~4% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in its report on the global real-time clock IC market. A real-time clock IC is a
Healthcare Packaging Market: Explore Top Factors that Will Boost the Global Mark …
Healthcare Packaging Market: Introduction The latest report published by Transparency Market Research on the global healthcare packaging market, includes global industry analysis, share, size, growth trends and forecast for 2021-2029. The current value of the global healthcare packaging market is US$ 100 Bn and is anticipated to expand to US$ 155 Bn by the year 2029. Growth of the pharmaceutical industry and high demand for medicinal supplies & drugs have created

All 5 Releases


More Releases for Chronic

Narcotic Analgesics: Future of Chronic Pain Management
The development of tolerance for non-narcotic analgesics is the primarily reason behind the constantly increasing sales for narcotic analgesics. Attributing to the higher efficacy in pain management and quick onset of action, narcotic analgesics are largely used in palliative care services for treating patients suffering from neuropathic pain. Increasing focus on palliative care services in third world countries and readily available reimbursements are the key factors expected to boost the
Global Chronic Bacterial Prostatitis Market Research Report
Latest industry research report on: Global Chronic Bacterial Prostatitis Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Bacterial Prostatitis Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Bacterial Prostatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Bacterial Prostatitis. Report includes an overview of trial numbers and their average
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation
Chronic Kidney Disease (Chronic Renal Failure) Market Research, Size, Trends, Gl …
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015 Summary Clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and their average enrollment in top